Company news
Icon Plc (NASDAQ:ICLR) news
Icon Plc news releases on 6ix. Latest, Aug 20, 2026: ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation…
Press releases & updates
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
August 20, 2026
ICON Announces Pricing of USD 2.15 Billion Notes
August 6, 2026
ICON Announces Private Offering of Notes
August 4, 2026
ICON Reports Second Quarter 2026 Results
July 28, 2026
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
July 28, 2026
ICON Schedules Second Quarter 2026 Earnings Conference Call
July 22, 2026
ICON Reports First Quarter 2026 Results
June 23, 2026
ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development
June 22, 2026
ICON Schedules First Quarter 2026 Earnings Conference Call
June 17, 2026
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
May 27, 2026
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq
May 26, 2026
ICON expands US early phase research capabilities with new clinic and outpatient centres
May 13, 2026
HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem
May 5, 2026
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results
April 29, 2026
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model
March 23, 2026
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices
February 12, 2026
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
December 8, 2025
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
December 1, 2025
ICON plc to Present at the Jefferies London Healthcare Conference
November 11, 2025
ICON Reports Third Quarter 2025 Results
October 21, 2025
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
September 23, 2025
ICON Announces CEO Transition
September 3, 2025
ICON plc to Participate at Upcoming Investor Conferences
September 1, 2025
ICON Reports Second Quarter 2025 Results
July 22, 2025
ICON Announces Results of Annual General Meeting
July 22, 2025
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
July 15, 2025
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
July 6, 2025
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
June 22, 2025
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
May 26, 2025
ICON releases its ICON Cares 2024 Report
May 18, 2025
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
May 6, 2025
ICON Reports First Quarter 2025 Results
April 29, 2025
ICON plc Schedules First Quarter 2025 Earnings Conference Call
March 30, 2025
ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review
March 19, 2025
ICON plc to Present at Upcoming Investor Conferences
March 4, 2025
Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
March 3, 2025
ICON Reports Fourth Quarter and Full Year 2024 Results
February 18, 2025
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
January 29, 2025
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
January 28, 2025
ICON Issues Financial Guidance for Full Year 2025
January 13, 2025
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
January 7, 2025
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
December 22, 2024
ICON Announces Appointment of Chief Operating Officer
December 17, 2024
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
December 4, 2024
ICON Reports Third Quarter 2024 Results
October 22, 2024
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
September 26, 2024
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
September 11, 2024
ICON plc to Present at the Baird 2024 Global Healthcare Conference
September 2, 2024